📰 Andreaf Wainer News
Page 16 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
April 7, 2024
Sky Investment Group LLC reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 109,217 shares of the healthcare product maker’s stock after selling 907 shares during the quarter. Abbott Laboratories accounts for […]
April 6, 2024
Traveka Wealth LLC bought a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 3,076 shares of the healthcare product maker’s stock, valued at approximately $339,000. A number of other hedge funds and […]
April 6, 2024
Campbell Newman Asset Management Inc. reduced its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 134,746 shares of the healthcare product maker’s stock after selling 2,083 shares during […]
April 6, 2024
Stratos Wealth Advisors LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 38,287 shares of the healthcare product maker’s stock after selling 1,021 shares during the period. […]
April 6, 2024
Stratos Wealth Advisors LLC lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 38,287 shares of the healthcare product maker’s stock after selling 1,021 shares during the period. Stratos Wealth Advisors LLC’s holdings in Abbott Laboratories were worth $4,214,000 as of its […]
April 6, 2024
Prime Capital Investment Advisors LLC boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 73,491 shares of the healthcare product maker’s stock after purchasing an additional 2,152 shares during the quarter. Prime Capital […]
April 6, 2024
Park Place Capital Corp decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,180 shares of the healthcare product maker’s stock after selling 148 shares during the quarter. […]
April 6, 2024
Stratos Wealth Advisors LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 38,287 shares of the healthcare product maker’s stock after selling 1,021 shares during the period. […]
April 5, 2024
KRS Capital Management LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,122 shares of the healthcare product maker’s stock after selling 462 shares during the quarter. Abbott Laboratories comprises 0.9% of […]
April 5, 2024
First Bancorp Inc ME trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 34.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 4,699 shares of the healthcare product maker’s stock after selling 2,494 shares during the quarter. First Bancorp Inc ME’s holdings in Abbott Laboratories were worth $517,000 at the end of […]